| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Cell Growth Regulation Laboratory, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030 [R. V., L. A., B. T., R. K.]; and Unidade de Oncologia, Hospital de Santa Maria, Lisbon 1500, Portugal [L. C.]
Activation of heregulin (HRG) signaling has been implicated in the development of aggressive phenotype in breast cancer cells. The mechanisms through which HRG regulates the progression of breast cancer cells to a more invasive or motile phenotype are currently unknown. Because the process of cell migration must involve dynamic changes in the formation of new focal adhesions at the leading edge and dissolution of preexisting focal points, we explored the potential HRG regulation of paxillin, a major component of focal adhesion. Here, we report that HRG stimulation of noninvasive breast cancer MCF-7 cells resulted in the up-regulation of paxillin mRNA and protein. The observed HRG stimulation of paxillin mRNA expression was completely blocked by actinomycin D (a transcriptional inhibitor) as well as by cycloheximide (a protein synthesis inhibitor), suggesting the involvement of an inducible protein factor(s) and transcriptional regulation of paxillin mRNA by HRG. Extension of these observations to other HRG-responsive human cell lines also demonstrated that HRG has a significant capacity to up-regulate the paxillin expression. Furthermore, the levels of paxillin expression were closely linked with the coexpression of human epidermal growth factor receptor 2 (HER2)/HER3 receptors in breast cancer cell lines and in grade III human breast tumors. This study is the first demonstration of regulation of paxillin expression by a polypeptide growth factor, and it suggests a potential role for paxillin in the HER2 pathway in breast cancer.
This article has been cited by other articles:
![]() |
Y. Tatsumi, Y.-Y. Cho, Z. He, H. Mizuno, H. Seok Choi, A. M. Bode, and Z. Dong Involvement of the Paxillin Pathway in JB6 Cl41 Cell Transformation Cancer Res., June 1, 2006; 66(11): 5968 - 5974. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Barnes, F. Li, A. H. Talukder, and R. Kumar Growth Factor Regulation of a 26S Proteasomal Subunit in Breast Cancer Clin. Cancer Res., April 15, 2005; 11(8): 2868 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suenaga, N. Takada, M. Hatakeyama, M. Ichikawa, X. Yu, K. Tomii, N. Okimoto, N. Futatsugi, T. Narumi, M. Shirouzu, et al. Novel Mechanism of Interaction of p85 Subunit of Phosphatidylinositol 3-Kinase and ErbB3 Receptor-derived Phosphotyrosyl Peptides J. Biol. Chem., January 14, 2005; 280(2): 1321 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Brown and C. E. Turner Paxillin: Adapting to Change Physiol Rev, October 1, 2004; 84(4): 1315 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hopkins, M. Bruewer, G. T. Brown, A. A. Pineda, J. J. Ha, L. M. Winfree, S. V. Walsh, B. A. Babbin, and A. Nusrat Epithelial cell spreading induced by hepatocyte growth factor influences paxillin protein synthesis and posttranslational modification Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G886 - G898. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Talukder, A. Gururaj, S. K. Mishra, R. K. Vadlamudi, and R. Kumar Metastasis-Associated Protein 1 Interacts with NRIF3, an Estrogen-Inducible Nuclear Receptor Coregulator Mol. Cell. Biol., August 1, 2004; 24(15): 6581 - 6591. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Didier, L. Broday, A. Bhoumik, S. Israeli, S. Takahashi, K. Nakayama, S. M. Thomas, C. E. Turner, S. Henderson, H. Sabe, et al. RNF5, a RING Finger Protein That Regulates Cell Motility by Targeting Paxillin Ubiquitination and Altered Localization Mol. Cell. Biol., August 1, 2003; 23(15): 5331 - 5345. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-W. Tsai, S.-G. Shiah, M.-T. Lin, C.-W. Wu, and M.-L. Kuo Up-regulation of Vascular Endothelial Growth Factor C in Breast Cancer Cells by Heregulin-beta 1. A CRITICAL ROLE OF p38/NUCLEAR FACTOR-kappa B SIGNALING PATHWAY J. Biol. Chem., February 14, 2003; 278(8): 5750 - 5759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Barnes, F. Li, M. Mandal, Z. Yang, A. A. Sahin, and R. Kumar Heregulin Induces Expression, ATPase Activity, and Nuclear Localization of G3BP, a Ras Signaling Component, in Human Breast Tumors Cancer Res., March 1, 2002; 62(5): 1251 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ayaki, K. Komatsu, M. Mukai, K. Murata, M. Kameyama, S. Ishiguro, J. Miyoshi, M. Tatsuta, and H. Nakamura Reduced Expression of Focal Adhesion Kinase in Liver Metastases Compared with Matched Primary Human Colorectal Adenocarcinomas Clin. Cancer Res., October 1, 2001; 7(10): 3106 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazumdar, L. Adam, D. Boyd, and R. Kumar Heregulin Regulation of Urokinase Plasminogen Activator and its Receptor: Human Breast Epithelial Cell Invasion Cancer Res., January 1, 2001; 61(1): 400 - 405. [Abstract] [Full Text] |
||||
![]() |
A. H. Talukder, R. Vadlamudi, M. Mandal, and R. Kumar Heregulin Induces Expression, DNA Binding Activity, and Transactivating Functions of Basic Leucine Zipper Activating Transcription Factor 4 Cancer Res., January 1, 2000; 60(2): 276 - 281. [Abstract] [Full Text] |
||||
![]() |
A. H. Talukder, L. Adam, A. Raz, and R. Kumar Heregulin Regulation of Autocrine Motility Factor Expression in Human Tumor Cells Cancer Res., January 1, 2000; 60(2): 474 - 480. [Abstract] [Full Text] |
||||
![]() |
R. K. Vadlamudi, L. Adam, R.-A. Wang, M. Mandal, D. Nguyen, A. Sahin, J. Chernoff, M.-C. Hung, and R. Kumar Regulatable Expression of p21-activated Kinase-1 Promotes Anchorage-independent Growth and Abnormal Organization of Mitotic Spindles in Human Epithelial Breast Cancer Cells J. Biol. Chem., November 10, 2000; 275(46): 36238 - 36244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mandal, R. Vadlamudi, D. Nguyen, R.-A. Wang, L. Costa, R. Bagheri-Yarmand, J. Mendelsohn, and R. Kumar Growth Factors Regulate Heterogeneous Nuclear Ribonucleoprotein K Expression and Function J. Biol. Chem., March 23, 2001; 276(13): 9699 - 9704. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |